Burkitt's Lymphoma

Explore clinical trials studying Burkitt's Lymphoma. Study availability and eligibility vary by location and protocol.

17 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Burkitt's Lymphoma trial results

Completed

MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine

NCT01397825

Conditions: Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +20 more
Locations: Tucson, Arizona, United States

Beverly Hills, California, United States

Burbank, California, United States

Miami, Florida, United States

View all 25 locations

View Trial Details

Completed

Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma

NCT00807495

Conditions: Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +22 more
Locations: Hematology Oncology Associates, Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States

View Trial Details

Completed

Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults

NCT01809600

Conditions: Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +16 more
Locations: Gachon University Gil Medical Center Incheon, South Korea

View Trial Details

Completed

Imexon for Relapsed Follicular and Aggressive Lymphomas

NCT01314014

Conditions: Burkitt Lymphoma, Burkitt's Lymphoma, Chronic Disease, +34 more
Locations: Arizona Cancer Center, University of Arizona Tucson, Arizona, United States

University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Rituximab Combined With Chemotherapy in Burkitt's Lymphoma

NCT00388193

Conditions: Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Burkitt's Lymphoma, +20 more
Locations: Hospital General de Alicante Alicante, Spain

Hospital "Santa Creu i Sant Pau" Barcelona, Spain

Hospital Clínico y Provincial de Barcelona Barcelona, Spain

Hospital Juan Canalejo A Coruña, La Coruña, Spain

View all 15 locations

View Trial Details

Completed

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients

NCT00949741

Conditions: Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +22 more
Locations: ASO SS Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy

PO Centro Binaghi Divisione di Ematologia CTMO Cagliari, CA, Italy

Az. Ospedaliero Universitaria Careggi Florence, FI, Italy

Ospedale Vito Fazzi Divisione di Ematologia Lecce, LE, Italy

View Trial Details

Completed

Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients

NCT00412243

Conditions: Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Burkitt's Lymphoma, +21 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Burkitt's Lymphoma

Burkitt's Lymphoma trial results

MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine

Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma

Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults

Imexon for Relapsed Follicular and Aggressive Lymphomas

Rituximab Combined With Chemotherapy in Burkitt's Lymphoma

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients

Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients

Related conditions